Genomics, proteomics and integrative 'omics' in hypertension research

Current Opinion in Nephrology and Hypertension

Volumn 14, Issue 2, 2005, Pages 133-139

  Thongboonkerd, Visith ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Genomics; Hypertension; Integrative omics; Kidney; Nephrology; Proteomics; Systems biology

Indexed keywords

ADRENERGIC SYSTEM; BIOINFORMATICS; ESSENTIAL HYPERTENSION; GENE EXPRESSION; GENE INTERACTION; GENETIC LINKAGE; GENETIC PREDISPOSITION; GENOMICS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYPERTENSION; HYPOXIA; KALLIKREIN KININ SYSTEM; MASS SPECTROMETRY; MOLECULAR MECHANICS; MUTAGENESIS; NONHUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; PHARMACOGENETICS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEOMICS; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW;

EID: 15444368510     PISSN: 10624821     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041552-200503000-00008     Document Type: Review

References (45)

1. Kaplan NM. Systemic hypertension: mechanisms and diagnosis. In: Braunwald E, editor. Heart Disease. A textbook of cardiovascular medicine 5th ed. Pennsylvania: W.B. Saunders Company; 1997. pp. 807-839.
2. O'Shaughnessy KM. The genetics of essential hypertension. Br J Clin Pharmacol 2001; 51:5-11.
3. Lifton RP, Gharavi AG, Geller DS. Molecular mechanisms of human hypertension. Cell 2001; 104:545-556.
4. Lee WK, Padmanabhan S, Dominiczak AF. Genetics of hypertension: from experimental models to clinical applications. J Hum Hypertens 2000; 14:631-647.
5. Timberlake DS, O'Connor DT, Parmer RJ. Molecular genetics of essential hypertension: recent results and emerging strategies. Curr Opin Nephrol Hypertens 2001; 10:71-79.
6. Hopkins PN, Hunt SC. Genetics of hypertension. Genet Med 2003; 5:413-429. A thorough review for molecular genetics of hypertension. Some results of genome-wide scans are summarized.
7. Garcia EA, Newhouse S, Caulfield MJ, Munroe PB. Genes and hypertension. Curr Pharm Des 2003; 9:1679-1689.
8. Harrap SB. Where are all the blood-pressure genes? Lancet 2003; 361:2149-2151.
9. Mein CA, Caulfield MJ, Dobson RJ, Munroe PB. Genetics of essential hypertension. Hum Mol Genet 2004; 13:R169-R175. An excellent review of the genetics of essential hypertension. Results from genome-wide scans for blood pressure, hypertension and pre-eclampsia genes are summarized and discussed.
10. Levy D, DeStefano AL, Larson MG, et al. Evidence for a gene influencing blood pressure on chromosome 17. Genome scan linkage results for longitudinal blood pressure phenotypes in subjects from the Framingham Heart Study. Hypertension 2000; 36:477-483.
11. Rice T, Rankinen T, Province MA, et al. Genome-wide linkage analysis of systolic and diastolic blood pressure: the Quebec Family Study. Circulation 2000; 102:1956-1963.
12. Rice T, Rankinen T, Chagnon YC, et al. Genomewide linkage scan of resting blood pressure: HERITAGE Family Study. Health, Risk Factors, Exercise Training, and Genetics. Hypertension 2002; 39:1037-1043.
13. Hunt SC, Ellison RC, Atwood LD, et al. Genome scans for blood pressure and hypertension: the National Heart, Lung, and Blood Institute Family Heart Study. Hypertension 2002; 40:1-6.
14. Thiel BA, Chakravarti A, Cooper RS, et al. A genome-wide linkage analysis investigating the determinants of blood pressure in whites and African Americans. Am J Hypertens 2003; 16:151-153. A recent report of a genome-wide scan published during the review period.
15. Perola M, Kainulainen K, Pajukanta P, et al. Genome-wide scan of predisposing loci for increased diastolic blood pressure in Finnish siblings. J Hypertens 2000; 18:1579-1585.
16. Kardia SL, Rozek LS, Krushkal J, et al. Genome-wide linkage analyses for hypertension genes in two ethnically and geographically diverse populations. Am J Hypertens 2003; 16:154-157. A recent report of a genome-wide scan published during the review period.
17. Rao DC, Province MA, Leppert MF, et al. A genome-wide affected sibpair linkage analysis of hypertension: the HyperGEN network. Am J Hypertens 2003; 16:148-150. A recent report of a genome-wide scan published during the review period.
18. von Wowern F, Bengtsson K, Lindgren CM, et al. A genome wide scan for early onset primary hypertension in Scandinavians. Hum Mol Genet 2003; 12:2077-2081. A recent report of a genome-wide scan published during the review period.
19. Koivukoski L, Fisher SA, Kanninen T, et al. Meta-analysis of genome-wide scans for hypertension and blood pressure in Caucasians shows evidence of susceptibility regions on chromosomes 2 and 3. Hum Mol Genet 2004; 13:2325-2332. This excellent meta-analysis of genome-wide scans should be used as a reference for upcoming genome scans.
20. Veerasingham SJ, Sellers KW, Raizada MK. Functional genomics as an emerging strategy for the investigation of central mechanisms in experimental hypertension. Prog Biophys Mol Biol 2004; 84:107-123. This review provides a good overview and some perspectives of functional genomics for hypertension research.
21. Durier S, Fassot C, Laurent S, et al. Physiological genomics of human arteries: quantitative relationship between gene expression and arterial stiffness. Circulation 2003; 108:1845-1851. This is one of the first studies in humans in which gene-expression profiles in tissue isolated from individual patients are correlated with a clinically relevant cardiovascular phenotype.
22. Glueck SB, Dzau VJ. Physiological genomics: implications in hypertension research. Hypertension 2002; 39:310-315.
23. Pravenec M, Wallace C, Aitman TJ, Kurtz TW. Gene expression profiling in hypertension research: a critical perspective. Hypertension 2003; 41:3-8.
24. Fries RS, Mahboubi P, Mahapatra NR, et al. Neuroendocrine transcriptome in genetic hypertension: multiple changes in diverse adrenal physiological systems. Hypertension 2004; 43:1301-1311.
25. Philip-Couderc P, Smih F, Pelat M, et al. Cardiac transcriptome analysis in obesity-related hypertension. Hypertension 2003; 41:414-421.
26. Rathkolb B, Fuchs E, Kolb HJ, et al. Large-scale N-ethyl-N-nitrosourea mutagenesis of mice-from phenotypes to genes. Exp Physiol 2000; 85:635-644.
27. McBride MW, Charchar FJ, Graham D, et al. Functional genomics in rodent models of hypertension. J Physiol 2004; 554:56-63.
28. Takahashi N, Smithies O. Human genetics, animal models and computer simulations for studying hypertension. Trends Genet 2004; 20:136-145.
29. Thongboonkerd V, Klein JB. Proteomics and hypertension. In: Thongboonkerd V, Klein JB, editors. Proteomics in nephrology. Basel: Karger; 2004. pp. 245-256. An oriented overview of proteomics applied to systemic hypertension. Future perspectives for this field are provided as well.
30. Pleissner KP, Regitz-Zagrosek V, Krudewagen B, et al. Effects of renovascular hypertension on myocardial protein patterns: analysis by computer-assisted two-dimensional gel electrophoresis. Electrophoresis 1998; 19:2043-2050.
31. Thongboonkerd V, Gozal E, Sachleben LR, et al. Proteomic analysis reveals alterations in the renal kallikrein pathway during hypoxia-induced hypertension. J Biol Chem 2002; 277:34708-34716.
32. Pinet F, Poirier F, Fuchs S, et al. Troponin T as a marker of differentiation revealed by proteomic analysis in renal arterioles. FASEB J 2004; 18:585-586. A recent study that underscores the potential of proteomics in hypertension and vascular research.
33. Fuchs D, Pascual-Teresa S, Rimbach G, et al. Proteome analysis for identification of target proteins of genistein in primary human endothelial cells stressed with oxidized LDL or homocysteine. Eur J Nutr 2004; 22:1-10. A recent study that underscores the potential of proteomics in hypertension and vascular research.
34. Lim CK, Lord G. Current developments in LC-MS for pharmaceutical analysis. Biol Pharm Bull 2002; 25:547-557.
35. Iyer RA, Malhotra B, Khan S, et al. Comparative biotransformation of radiolabeled [(14)C]Omapatrilat and stable-labeled [(13)C(2)]Omapatrilat after oral administration to rats, dogs, and humans. Drug Metab Dispos 2003; 31:67-75.
36. Kim Y, Hwang J, Kim M, Lee W. Determination of Tripamide in human urine by high-performance liquid chromatography and high-performance liquid chromatography/electrospray ionization tandem mass spectrometry. Rapid Commun Mass Spectrom 2003; 17:301-306.
37. Garzotti M. Lacidipine, a potential peroxynitrite scavenger: investigation of activity by liquid chromatography and mass spectrometry. Rapid Commun Mass Spectrom 2003; 17:272-278.
38. Jain KK. Proteomics and drug discovery. In: Thongboonkerd V, Klein JB, editors. Proteomics in nephrology. Basel: Karger; 2004. pp. 308-327.
39. Chapman AB, Schwartz GL, Boerwinkle E, Turner ST. Predictors of antihypertensive response to a standard dose of hydrochlorothiazide for essential hypertension. Kidney Int 2002; 61:1047-1055.
40. Trotta R, Donati MB, Iacoviello L. Trends in pharmacogenomics of drugs acting on hypertension. Pharmacol Res 2004; 49:351-356.
41. Cadman PE, O'Connor DT. Pharmacogenomics of hypertension. Curr Opin Nephrol Hypertens 2003; 12:61-70. This review provides an overview and basic concepts of pharmacogenomics applied to pharmacokinetics and pharmacodynamics.
42. Morel NM, Holland JM, van der GJ, et al. Primer on medical genomics. Part XIV: Introduction to systems biology - a new approach to understanding disease and treatment. Mayo Clin Proc 2004; 79:651-658. An excellent overview that provides basic concepts of systems biology for medical diseases.
43. Ge H, Walhout AJ, Vidal M. Integrating 'omic' information: a bridge between genomics and systems biology. Trends Genet 2003; 19:551-560. This paper provides an excellent overview, as well as examples of integrative omics and its application to systems biology.
44. Weston AD, Hood L. Systems biology, proteomics, and the future of health care: toward predictive, preventative, and personalized medicine. J Proteome Res 2004; 3:179-196. An elegant discussion of systems biology and the future of health care. Not only basic concepts, but also some results of systems biology are discussed.
45. Clish CB, Davidov E, Oresic M, et al. Integrative biological analysis of the APOE*3-leiden transgenic mouse. OMICS 2004; 8:3-13. The first-ever systems biology applied to mammalian diseases. The authors have proposed a model of the interaction network of genes, transcripts and proteins identified in this study.